Clinical trial Recruiting at 1 site Observational Ages 18 and up

SPECT/CT Performance Comparison Using StarGuide GX in Adults

Official title: Demonstration of the StarGuide GX SPECT/CT System

Run by GE Healthcare · NCT07725237 · Data updated 2026-11-12

This study tests whether the StarGuide GX SPECT/CT scan matches the results of a patient’s clinically indicated SPECT/CT in adults.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorGE Healthcare
Industry-sponsored
Locations1 site (Haifa)
StatusRecruiting
StartedJuly 20, 2026
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedAugust 19, 2026
Trial IDNCT07725237 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older who have a clinically indicated SPECT/CT exam scheduled and can provide informed consent.

Probably not a fit

Patients without a comparable or interpretable baseline SPECT/CT may not benefit from additional imaging data.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this observational study, adults undergoing a clinically indicated SPECT/CT will receive an additional StarGuide GX SPECT/CT scan. The imaging data from StarGuide GX will be compared to the participant’s standard SPECT/CT results to evaluate concordance. The study aims to collect image data in a real clinical setting to assess the StarGuide GX system’s performance. Participation is limited to those who can consent and have an appropriate clinical scan scheduled. GE Healthcare leads the trial with Rambam Health Care Campus as a collaborating site.

Why it matters

Potential benefit: If successful, the StarGuide GX system may provide reliable imaging data that could influence future clinical imaging practices.

How similar studies have gone: Prior studies with similar technologies have demonstrated useful comparisons between new SPECT/CT platforms and standard scanners.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult, who is at least 18 years of age, on day of consent.
* Must have a clinically indicated SPECT/CT exam scheduled according to current clinical practice standards; AND
* Able and willing to provide informed consent for participation in this study.

Exclusion Criteria:

* Who, per the site's Standard Operating Procedures (SOPs), has any condition that would prevent the clinically indicated SPECT/CT from proceeding (i.e., pregnancy, breastfeeding, renal impairment, etc.);
* Who were previously enrolled in this study;
* Who need urgent or emergent care;
* Who have any conditions that, in the opinion of the Principal Investigator (PI) or designee, would interfere with the evaluation of the results, or constitute a health hazard for the participant;
* Unwilling to have GE Healthcare personnel present during scans; OR
* Unable to tolerate the exam.

Where it's running

  • Rambam Health Care Campus
    Haifa, Israel
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.